Phosphate binders on iron basis: A new perspective?

Kidney International, Supplement

Volumn 56, Issue 73, 1999, Pages

  Hergesell, Olaf ^a   Ritz, Eberhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hemodialysis; Hyperphosphatemia; Iron; Phosphate binders; Renal failure

Indexed keywords

ALUMINUM DERIVATIVE; CALCIUM ACETATE; CALCIUM CARBONATE; FERRIC AMMONIUM CITRATE; FERRIC CHLORIDE; FERRIC CITRATE; FERRIC HYDROXIDE; LANTHANUM CARBONATE; PHOSPHATE; PHOSPHATE BINDING AGENT; SEPHADEX; SEVELAMER; UNCLASSIFIED DRUG; IRON;

ARTICLE; DRUG EFFICACY; DRUG ELIMINATION; DRUG INTOXICATION; DRUG SAFETY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; NONHUMAN; PHOSPHATE EXCRETION; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; TREATMENT OUTCOME; UREMIA; ANIMAL; METABOLISM; RAT; RENAL REPLACEMENT THERAPY; REVIEW;

ANIMALS; HUMANS; IRON; PHOSPHATES; RATS; RENAL DIALYSIS;

EID: 0033377039     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.07311.x     Document Type: Article

References (31)

1. AMANN K, GROSS ML, LONDON GM, RITZ E: Hyperphosphatemia - a silent killer of patients with renal failure? Nephrol Dial Transplant 14:2085-2087, 1999
2. SCHAEFER K: Alternative phosphate binders: an update. Nephrol Dial Transplant 1:35-39, 1993
3. 45Ca studies in dialysis patients. Clin Nephrol 34:35-41, 1990
4. HOU SH, ZHAO J, ELLMANN CF, HU J, GRIFFIN Z, SPIEGEL DM, BOURDEAU JE: Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 18:217-224, 1991
5. RITZ E: Phosphate removal during dialysis - does the membrane matter? Clin Nephrol 42 (Suppl.):S57-S60, 1994
6. ZUCCHELLI P, SANTORO A: Inorganic phosphate removal during different dialysis procedures. Int J Artif Organs 10:173-178, 1987
7. POGGLITSCH H, PETEK W, ZIAK E, STERZ F, HOLZER H: Phosphorus kinetics during hemodialysis and hemofiltration. Proc EDTA-ERA 21:461-468, 1984
8. MUCSI I, HERCZ G, ULDALL R, OUWENDYK M, FRANCOEUR R, PIERRATOS A: Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53:1399-1404, 1998
9. MUCSI I, HERCZ G: Control of serum phosphate in patients with renal failure - new approaches. Nephrol Dial Transplant 13:2457-2460, 1998
10. RITZ E, PASSLICK-DEETJEN J, LIPPERT J: What is the appropriate dialysate calcium concentration for the dialysis patient? Nephrol Dial Transplant 11 (Suppl. 3):91-95, 1996
11. ARGILES A, KERR PG, CANAUD B, FLAVIER JL, MION C: Calcium kinetics and the long-term effects of lowering dialyste calcium concentration. Kidney Int 43:630-640, 1993
12. WILLS MR, SAVORY J: Aluminium poisoning: dialysis encephalopathy, osteomalacia and anemia. Lancet 2:29-34, 1983
13. CHERTOW GM, BURKE SK, LAZARUS JM, STENZEL KH, WOMBOLT D, GOLDBERG D, BONVENTRE JV, SLATOPOLSKY E: Poly[allylamine Hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis 29:66-71, 1997
14. SLATOPOLSKY EA, BURKE SK, DILLON MA AND THE RENAGEL STUDY GROUP: RenaGel, a nonabsorbed calcium and aluminium-free phosphate binder, lowers serum phophorus and parathyroid hormone. Kidney Int 55:299-307, 1999
15. BLEYER AJ, BURKE SK, DILLON M, GARRETT B, KANT KS, LYNCH D, RAHMAN SN, SCHOENFELD P, TEITELBAUM I, ZEIG S, SLATOPOLSKY E: A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33:694-701, 1999
16. GRAFF L, BURNEL D: a possible non-luminium oral phosphate binder? A comparative study on the dietary phosphorus absorption. Res Commun Mol Pathol Pharmacol 89:373-378, 1995
17. LIU SH, CHU HI, HSU HC, CHAO HC, CHEU SH: Calcium and phosphorus metabolism in osteomalacia. J Clin Invest 20:255-271, 1941
18. LIU SH, CHU HI: Studies of calcium and phosphorus metabolism with special reference to pathogcnesis and effects of dihydrotachysterol (A.T.10) and iron. Medicine (Baltimore) 22:103-161, 1943
19. OKADA M, IMAMURA K, IIDAM, FUCHIGAMI T, OMAE T: Hypophosphatemia induced by intravenous administration of saccharated iron oxide. Klin Wochenschr 61:99-102, 1983
20. COX G, DODDS M, WIGMAN H, MURPHY F: The effects of high doses of aluminium and iron on phosphorus metabolism. J Biol Chem 92:xi-xii, 1931
21. BROCK J, DIAMOND L: Rickets in rats by iron feeding. J Pediat 4:442-453, 1934
22. REHM P, WINTERS J: The effect of ferric chloride utilization of calcium and phosphorus in the animal body. J Nutr 19:213-222, 1940
23. DEOBALD H, ELVEHJEM C: The effect of feeding high amounts of soluble iron and aluminium salts. Am J Physiol 111:118-123, 1935
24. FURUGOURI K: Effect of elevated dietary levels of iron stores in liver, some blood constituents and phosphorus deficiency in young swine. J Animal Sci 34:573-577, 1972
25. SPENGLER K, FOLLMANN H, BOOS KS, SEIDEL D, VON DER HAAR F, ELSNER R, MAYWALD F: cross-linked iron dextran is an efficient oral phosphate binder in the rat. Nephrol Dial Transplant 11:808-812, 1996
26. BOOS KS, SEIDEL D, RAUH A, SPENGLER K, HENKE G: Verfahren zur selektiven Elimination von anorganischem Phosphat aus Flüssigkeiten mittels polynuclearen Metalloxidhydroxid-modifizierten Adsorptionsmaterialien. German Pat Appl P41 39 442.2, 1992
27. SPENGLER K, FOLLMANN H, BOOS KS, SEIDEL D, MAYWALD F: Characterisation and extracorporeal application of a new phosphate-binding agent. Eur J Clin Chem Clin Biochem 32:733-739, 1994
28. HSU CS, PATEL SR, YOUNG EW: New phosphate binding agents: ferric compounds. J Am Soc Nephrol 10:1274-1280, 1999
29. HERGESELL O, RITZ E: Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients. Nephrol Dial Transplant 14:863-867, 1999
30. CHANG JM, HWANG SJ, TSAI JC, CHEN HC, GUH JY, LAI YH: Effect of ferric polymaltose complex as a phosphate binder in hemodialysis patients. Nephrol Dial Transplant 14:1045-1047, 1999
31. SHIMADA T, OKUDA S, MOTOMURA K, ONOYAMA K, FUJISHIMA M: Niceritorol decreases serum phosphate levels in hemodialysis patients - A randomized, double-blind, crossover study. J Am Soc Nephrol 7:52, 1996